Raphael Pharmaceutical (RAPH) Cash & Equivalents Growth (1y) (2021 - 2025)
Raphael Pharmaceutical (RAPH) Cash & Equivalents Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 120.45% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 12.78% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -32.64% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -57.43% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 37.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -12.11% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -12.07% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -18.80% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -46.88% |
| 10 | Raphael Pharmaceutical | - | - | - | 136.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 136.84% |
| Sep 30, 2025 | -92.50% |
| Jun 30, 2025 | -83.33% |
| Mar 31, 2025 | -82.58% |
| Dec 31, 2024 | -91.74% |
| Sep 30, 2024 | -86.62% |
| Jun 30, 2024 | 8.11% |
| Mar 31, 2024 | 655.26% |
| Dec 31, 2023 | -20.14% |
| Sep 30, 2023 | 221.51% |
| Jun 30, 2023 | -17.78% |
| Mar 31, 2023 | -53.09% |
| Dec 31, 2022 | 88.24% |
| Sep 30, 2022 | 151.35% |
| Dec 31, 2021 | 61.05% |
| Sep 30, 2021 | 2.78% |